Up­dat­ed: Mer­ck gives few de­tails on 2024 re­struc­tur­ing plan for man­u­fac­tur­ing net­work

Mer­ck re­cent­ly ap­proved a re­struc­tur­ing plan for this year, the glob­al phar­ma an­nounced dur­ing its full-year and fourth-quar­ter earn­ings re­port on Thurs­day.

Al­though Mer­ck didn’t in­clude de­tails, the re­struc­tur­ing pro­gram is meant to “con­tin­ue the op­ti­miza­tion of the com­pa­ny’s Hu­man Health glob­al man­u­fac­tur­ing net­work as the fu­ture pipeline shifts to new modal­i­ties, and al­so to op­ti­mize the An­i­mal Health glob­al man­u­fac­tur­ing net­work to im­prove sup­ply re­li­a­bil­i­ty and in­crease ef­fi­cien­cy,” the com­pa­ny said. The re­struc­tur­ing re­sult­ed in charges in its GAAP re­sults of $190 mil­lion.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER